Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
WeiShi
Enrollment target
~120 participants
Started
October 2025
Primary completion
October 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
wei MD, PhD
WeiShi